{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:13Z","timestamp":1791341533795,"version":"4.3.1"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["Z251100007125022"],"award-info":[{"award-number":["Z251100007125022"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090053"],"award-info":[{"award-number":["82090053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218798","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:58:59Z","timestamp":1787921939000},"page":"218798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target"],"prefix":"10.1016","volume":"660","author":[{"given":"Mehriban","family":"Bazar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6229-5690","authenticated-orcid":false,"given":"Xiaojuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"26","key":"10.1016\/j.canlet.2026.218798_bib2","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3748\/wjg.15.3210","article-title":"Current management strategy of hepatocellular carcinoma","volume":"15","author":"Rampone","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218798_bib3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/gast.2002.33411","article-title":"Hepatocellular carcinoma: diagnosis and treatment","volume":"122","author":"Befeler","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.canlet.2026.218798_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0040-1720950","article-title":"Treatment options for early-stage hepatocellular carcinoma","volume":"37","author":"Tabori","year":"2020","journal-title":"Semin. Interv. Radiol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib6","volume":"12","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.canlet.2026.218798_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","article-title":"Hepatocellular carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"36","author":"Vogel","year":"2025","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218798_bib8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2025.10.020","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update","volume":"84","author":"Reig","year":"2026","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218798_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.annonc.2024.02.005","article-title":"Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"35","author":"Sangro","year":"2024","journal-title":"Ann. Oncol."},{"issue":"20","key":"10.1016\/j.canlet.2026.218798_bib11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib12","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.canlet.2026.218798_bib14","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","article-title":"Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy","volume":"22","author":"Seyhan","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2026.218798_bib15","article-title":"Exploring the role of the immune microenvironment in hepatocellular carcinoma: implications for immunotherapy and drug resistance","volume":"13","author":"Yumin Fu","year":"2024","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"7791","key":"10.1016\/j.canlet.2026.218798_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.canlet.2026.218798_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.canlet.2026.218798_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib20","article-title":"Tertiary lymphoid structures and cancer immunotherapy: from bench to bedside","volume":"6","author":"Peyraud","year":"2025","journal-title":"M\u00e9d. Sur"},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-23-3325","article-title":"Exploiting tertiary lymphoid structures to stimulate antitumor immunity and improve immunotherapy efficacy","volume":"84","author":"Petroni","year":"2024","journal-title":"Cancer Res."},{"issue":"27","key":"10.1016\/j.canlet.2026.218798_bib22","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib23","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/cas.70105","article-title":"CXCL13 and CCL21 induce tertiary lymphoid structures and enhance the efficacy of immunotherapy for melanoma","volume":"116","author":"Yoshimitsu","year":"2025","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.canlet.2026.218798_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006667","article-title":"Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma","volume":"11","author":"Xu","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2026.218798_bib25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00262-019-02407-8","article-title":"The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer","volume":"68","author":"Sofopoulos","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib26","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","article-title":"Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma","volume":"70","author":"Calderaro","year":"2019","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib28","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41416-023-02396-7","article-title":"Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma","volume":"129","author":"Nakamura","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"6801","key":"10.1016\/j.canlet.2026.218798_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.adz2742","article-title":"Pan-cancer spatial atlas of tertiary lymphoid structures","volume":"392","author":"Cho","year":"2026","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/1744666X.2024.2380892","article-title":"Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy","volume":"20","author":"Langouo Fontsa","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218798_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218798_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"6576","key":"10.1016\/j.canlet.2026.218798_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-immunol-090222-102834","article-title":"T follicular helper cell heterogeneity","volume":"42","author":"Song","year":"2024","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218798_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nri3689","article-title":"Follicular dendritic cells: dynamic antigen libraries","volume":"14","author":"Heesters","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2007.12.001","article-title":"Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function","volume":"20","author":"Allen","year":"2008","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.20121462","article-title":"Endothelial cell-specific lymphotoxin-beta receptor signaling is critical for lymph node and high endothelial venule formation","volume":"210","author":"Onder","year":"2013","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.canlet.2026.218798_bib42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10456-021-09792-8","article-title":"High endothelial venules (HEVs) in immunity, inflammation and cancer","volume":"24","author":"Blanchard","year":"2021","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib44","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200264","article-title":"Tumor-infiltrating dendritic cell states are conserved across solid human cancers","volume":"218","author":"Gerhard","year":"2021","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.canlet.2026.218798_bib45","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218798_bib46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev.immunol.26.021607.090257","article-title":"Development of secondary lymphoid organs","volume":"26","author":"Randall","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218798_bib47","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri1054","article-title":"Organogenesis of lymphoid tissues","volume":"3","author":"Mebius","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218798_bib48","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","article-title":"Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation","volume":"35","author":"Peters","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20100052","article-title":"Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells","volume":"208","author":"Lochner","year":"2011","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9280","article-title":"NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures","volume":"6","author":"Carrega","year":"2015","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.canlet.2026.218798_bib52","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1084\/jem.20090410","article-title":"Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice","volume":"206","author":"GeurtsvanKessel","year":"2009","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.canlet.2026.218798_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.20111594","article-title":"Notch, Id2, and RORgammat sequentially orchestrate the fetal development of lymphoid tissue inducer cells","volume":"209","author":"Cherrier","year":"2012","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqab011","article-title":"Lymphoid stromal cells-more than just a highway to humoral immunity","volume":"2","author":"Cinti","year":"2021","journal-title":"Oxford Open Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218798_bib55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4049\/jimmunol.1701269","article-title":"Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity","volume":"200","author":"Engelhard","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2597587","article-title":"Targeting high endothelial venules: potential strategies for cancer treatment","volume":"57","author":"Yang","year":"2025","journal-title":"Ann. Med."},{"issue":"4","key":"10.1016\/j.canlet.2026.218798_bib57","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2326-6066.CIR-22-0112","article-title":"Tumor-associated high endothelial venules: inroads enabling immune control of cancer progression","volume":"10","author":"Gallimore","year":"2022","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid Neogenesis1","volume":"169","author":"Luther","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218798_bib59","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.20131737","article-title":"IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs","volume":"211","author":"Fleige","year":"2014","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218798_bib60","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"issue":"20","key":"10.1016\/j.canlet.2026.218798_bib61","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"de Chaisemartin","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218798_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib63","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.immuni.2023.02.003","article-title":"B cell receptor signaling in germinal centers prolongs survival and primes B cells for selection","volume":"56","author":"Chen","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218798_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102308","article-title":"Germinal center reaction and output: recent advances","volume":"82","author":"Liu","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218798_bib65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.20091777","article-title":"IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism","volume":"207","author":"Zotos","year":"2010","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.canlet.2026.218798_bib66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.it.2010.03.002","article-title":"Activation of B cells by antigens on follicular dendritic cells","volume":"31","author":"El Shikh","year":"2010","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"80","key":"10.1016\/j.canlet.2026.218798_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add1823","article-title":"IL-21R signal reprogramming cooperates with CD40 and BCR signals to select and differentiate germinal center B cells","volume":"8","author":"Luo","year":"2023","journal-title":"Sci. Immunol."},{"issue":"80","key":"10.1016\/j.canlet.2026.218798_bib69","doi-asserted-by":"crossref","first-page":"eadd1728","DOI":"10.1126\/sciimmunol.add1728","article-title":"Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation","volume":"8","author":"Chen","year":"2023","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2019.08.014","article-title":"The immunobiology of hepatocellular carcinoma in humans and mice: basic concepts and therapeutic implications","volume":"72","author":"Hou","year":"2020","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218798_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000516","article-title":"The immune microenvironment of steatotic hepatocellular carcinoma: current findings and future prospects","volume":"8","author":"Cheu","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.canlet.2026.218798_bib73","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.2147\/JIR.S435316","article-title":"Chronic inflammatory and immune microenvironment promote hepatocellular carcinoma evolution","volume":"16","author":"Chen","year":"2023","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib74","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","article-title":"Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside","volume":"13","author":"Yin","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2026.218798_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237469","article-title":"The complexity of the tumor microenvironment in hepatocellular carcinoma and emerging therapeutic developments","volume":"12","author":"Argentiero","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12916-025-03889-3","article-title":"Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer","volume":"23","author":"Xie","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.canlet.2026.218798_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112790","article-title":"Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis","volume":"140","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218798_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006425","article-title":"Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00535-022-01939-8","article-title":"Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma","volume":"58","author":"Tanaka","year":"2023","journal-title":"J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218798_bib80","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41416-023-02235-9","article-title":"Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors","volume":"128","author":"Hayashi","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2026.218798_bib81","article-title":"Prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma","volume":"35","author":"Pradhan","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.canlet.2026.218798_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1390938","article-title":"Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review","volume":"15","author":"Hu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11033-025-10319-3","article-title":"From heterogeneity to prognosis: understanding the complexity of tertiary lymphoid structures in tumors","volume":"52","author":"Wang","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.canlet.2026.218798_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008613","article-title":"Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2026.218798_bib85","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1097\/JS9.0000000000003045","article-title":"Refining risk stratification in hepatocellular carcinoma by integrating tertiary lymphoid structures and microvascular invasion: a multicenter retrospective study","volume":"111","author":"Ma","year":"2025","journal-title":"Int. J. Surg."},{"issue":"11","key":"10.1016\/j.canlet.2026.218798_bib86","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200269RR","article-title":"Tertiary lymphoid structures: associated multiple immune cells and analysis their formation in hepatocellular carcinoma","volume":"36","author":"Nie","year":"2022","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.canlet.2026.218798_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102144","article-title":"Lymphocyte function in tertiary lymphoid structures predicts hepatocellular carcinoma outcome","volume":"104","author":"Li","year":"2024","journal-title":"Lab. Invest."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib88","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1097\/JS9.0000000000002568","article-title":"Tertiary lymphoid structures signature predicts prognosis and clinical benefits from neoadjuvant chemotherapy and PD-1 blockade in colorectal adenocarcinoma","volume":"111","author":"Guo","year":"2025","journal-title":"Int. J. Surg."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib89","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/cam4.5227","article-title":"Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218798_bib90","article-title":"Peritumoral tertiary lymphoid structures correlate with protective immunity and improved prognosis in patients with hepatocellular carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib91","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011126","article-title":"Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study","volume":"13","author":"Long","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2026.218798_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009879","article-title":"Spatial patterns and MRI-based radiomic prediction of high peritumoral tertiary lymphoid structure density in hepatocellular carcinoma: a multicenter study","volume":"12","author":"Long","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218798_bib94","article-title":"Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker exploration","author":"Lin","year":"2025","journal-title":"J. Hepatol."},{"issue":"7957","key":"10.1016\/j.canlet.2026.218798_bib95","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-023-05771-9","article-title":"Antibodies against endogenous retroviruses promote lung cancer immunotherapy","volume":"616","author":"Ng","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.canlet.2026.218798_bib96","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009603","article-title":"Intratumoral CXCL13(+) CD160(+) CD8(+) T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib97","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1038\/s41467-024-52153-4","article-title":"Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.canlet.2026.218798_bib98","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib99","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib100","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1186\/s12885-025-15322-2","article-title":"The predictive value of intratumoral tertiary lymphoid structures on the response to immunotherapy in cancer patients: a systematic review and meta-analysis","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218798_bib101","article-title":"Tertiary lymphoid structures in HCC: influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy","author":"Su","year":"2025","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.canlet.2026.218798_bib102","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s13402-024-00975-1","article-title":"Tertiary lymphoid structures and their therapeutic implications in cancer","volume":"47","author":"Chen","year":"2024","journal-title":"Cell. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218798_bib103","article-title":"Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in hepatocellular carcinoma after FOLFOX-HAIC therapy","volume":"6","author":"Xing","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218798_bib104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41467-024-55430-4","article-title":"Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.canlet.2026.218798_bib105","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"issue":"21","key":"10.1016\/j.canlet.2026.218798_bib106","article-title":"The absence of intra-tumoral tertiary lymphoid structures is associated with a worse prognosis and mTOR signaling activation in hepatocellular carcinoma with liver transplantation: a multicenter retrospective study","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"2","key":"10.1016\/j.canlet.2026.218798_bib107","first-page":"127","article-title":"Artificial intelligence in cancer imaging: clinical challenges and applications","volume":"69","author":"Bi","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.canlet.2026.218798_bib108","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.30309","article-title":"The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"issue":"32","key":"10.1016\/j.canlet.2026.218798_bib109","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.3748\/wjg.v27.i32.5341","article-title":"Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: current status and future perspectives","volume":"27","author":"Feng","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218798_bib110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jmri.28982","article-title":"MRI-based radiomics and deep learning in biological characteristics and prognosis of hepatocellular carcinoma: opportunities and challenges","volume":"59","author":"Xia","year":"2024","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.canlet.2026.218798_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110309","article-title":"Preoperative prediction of intra-tumoral tertiary lymphoid structures based on CT in hepatocellular cancer","volume":"151","author":"Li","year":"2022","journal-title":"Eur. J. Radiol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526005628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:23:04Z","timestamp":1791339784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526005628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":111,"alternative-id":["S0304383526005628"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218798","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218798"}}